Asan Medical Center (AMC) and iProgen Biotech Inc., enters research collaboration to explore the application of Antibody Drug Conjugate technology to treat sarcopenia. iProgen will engineer ADC candidates and AMC will evaluate the effect of the candidate ADCs in treating sarcopenia.
Menu
